Alto Neuroscience, Inc. (ANRO)
24.91
-0.75
(-2.92%)
USD |
NYSE |
May 01, 16:00
24.91
0.00 (0.00%)
After-Hours: 16:36
Alto Neuroscience Market Cap : 795.76M for May 1, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Eli Lilly & Co. | 861.92B |
| Immunovant, Inc. | 5.518B |
| Halozyme Therapeutics, Inc. | 7.548B |
| Vertex Pharmaceuticals, Inc. | 107.72B |
| Fortress Biotech, Inc. | 75.19M |
Market Cap Related Metrics
| Price to Book Value | 5.265 |
| Price | 24.91 |
| Earnings Yield | -9.01% |